TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

US ANTIBIOTICS

Infectious DiseaseDermatology
Big Pharma

US ANTIBIOTICS is a major pharmaceutical company focused on Infectious Disease, Dermatology.

1979
Since
11
Drugs
-
Trials
46
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LEVOCETIRIZINE DIHYDROCHLORIDE 2026-01-07
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
5 drugs
Dermatology 50%
5 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology